13F Holdings
中文EN

ACBM ACRO BIOMEDICAL CO., LTD.

Services-Amusement & Recreation Services · OTC · SEC CIK 1622996 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-200.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-493.3%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets12,292.7%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.00x
Accruals ratio-1.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$0$0$0$658,500$1.20M
Cost of revenue——$0$518,000$938,000
Gross profit——$0$140,500$259,500
R&D expense—$0$4.79M$10.08M$5.29M
SG&A expense$154,024$37,958$3.52M$5.93M$2.67M
Operating income-$154,024-$37,958-$8.80M-$15.87M-$7.69M
Interest expense——$3,206$1,706$893
Pretax income-$101,146-$42,297-$8.81M-$15.87M—
Income tax$0$0$0$0$0
Net income-$101,146-$42,297-$8.81M-$15.87M-$7.70M
EPS (basic)————-0.14
EPS (diluted)0.000.00-0.15-0.26—
Weighted avg. shares (diluted)60.04M60.04M60.04M60.04M53.84M
Balance sheet
Cash & equivalents$4,098$476$376$5,852$95,248
Receivables——$0$638,500$598,000
Inventory————$0
Current assets$14,098$5,076$1,626$657,537$706,415
Total assets$14,098$31,974$58,459$687,486$761,077
Current liabilities$401,062$326,946$288,575$201,116$91,651
Total liabilities$401,062$326,946$315,473$201,116$117,370
Shareholders' equity-$386,964-$294,972-$257,014$486,370$643,707
Shares outstanding60.04M60.04M60.04M60.04M60.04M
Cash flow statement
Operating cash flow-$196,302-$36,692-$15,446-$147,481$299,335
Financing cash flow$199,924$36,792$9,970$58,085-$222,210
Stock-based compensation—$0$8.06M$15.71M$7.65M

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.